|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash | |||||||||
| Due from Sponsor | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Long-term prepaid insurance | |||||||||
| Cash held in Trust Account | |||||||||
| Total Assets | |||||||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit | |||||||||
| Current liabilities | |||||||||
| Accrued offering costs | |||||||||
| Advance from related party | |||||||||
| Due to related party | |||||||||
| Accrued expenses | |||||||||
| Promissory note - related party | |||||||||
| Total current liabilities | |||||||||
| Deferred underwriting fee | |||||||||
| Total Liabilities | |||||||||
| Class A ordinary shares subject to possible redemption, 8,409,633 and 23,000,000 shares at redemption value of approximately $10.87 and $10.68 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Class A shares subject to possible redemption | |||||||||
| Total class A ordinary shares subject to possible redemption, 8,409,633 and 23,000,000 shares at redemption value of approximately $10.87 and $10.68 per share as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Shareholders' Deficit | |||||||||
| Ordinary shares, Value | |||||||||
| Accumulated deficit | |||||||||
| Total Shareholders' Deficit | |||||||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders' Deficit |
Loading...
